| Financial Year |
March 31 2023 |
| Monetary Funds |
4,161,669,338.46 |
| Held-for-trading Financial Assets |
40,096,405.49 |
| Notes Receivable |
-- |
| Accounts Receivable |
30,282,801.94 |
| Advances to Suppliers |
110,462,530.93 |
| Other Receivables |
481,748,678.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,938,987,489.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
552,744,143.08 |
| Total Current Assets |
22,315,991,388.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,087,456,442.64 |
| Fixed Assetes |
53,331,776.74 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,728,110.75 |
| Deferred Income Tax Assets |
658,169,640.25 |
| Other Non-Current Assets |
2,297,316,234.02 |
| Sub-Total of Non-Current Assets |
4,177,863,396.94 |
| Total Assets |
26,493,854,785.53 |
| Short-Term Loans |
327,966,652.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,314,571,256.49 |
| Accounts Received In Advance |
1,321,841.45 |
| Employee Compensation Payable |
36,703,195.62 |
| Taxes Payable |
728,470,408.27 |
| Interest Payable |
74,353,973.06 |
| Dividend Payable |
6,209,507.61 |
| Other payables |
1,753,887,837.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,533,497,639.63 |
| Other Current Liabilities |
437,092,381.48 |
| Sub-Total of Current Liabilities |
10,996,137,493.71 |
| Long-term Loans |
6,162,643,063.32 |
| Bonds Payable |
824,754,775.64 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
153,460.32 |
| Deferred Income Tax Liabilities |
1,018,197.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,041,304,741.76 |
| Total Liabilities |
18,037,442,235.47 |
| Paid-In Capital(Or Share Stock) |
1,349,995,046.00 |
| Capital Surplus |
484,321,623.07 |
| Surplus Reserve |
2,178,265,346.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,877,181,443.36 |
| Minority Stockholder's Interest |
566,649,091.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,889,763,458.48 |
| Owner's Equity（Stockholder's Equity） |
8,456,412,550.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,493,854,785.53 |
